C12N 2710/24241
Use of virus, viral particle or viral elements as a vector
C12N2710/24241 (Use of virus, viral particle or viral elements as a vector) appears on 8 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 20
- Assignees
- 12
- Inventors
- 30
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 2 |
| 2025 | 2 | 2 |
By publication year.
Subgroups
Granted patents
- C12N 2710/24243Viral genome or elements thereof as genetic vectorIndexing code8
- C12N 2710/24242Virus or viral particle as vehicleIndexing code0
- C12N 2710/24244Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2710/24245Special targeting system for viral vectorsIndexing code0
Recent patents
- Recombinant pseudocowpoxvirus5 Aug 2025US 12,377,142 B2Transgene S. A.
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Recombinant Orf virus vector29 Mar 2022US 11,286,500 B2Eberhard Karls Universität Tübingen Medizinische Fakultät
- Orf virus-based platform for vaccine delivery25 May 2021US 11,013,798 B2Federal University of Santa Maria
- Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom25 Jul 2017US 9,714,272 B2AiCuris GmbH & Co. KG
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Modified parapoxvirus having increased immunogenicity2 Oct 2025US 2025/0304995 A1Prime Vector Technologies GmbH
- Modified parapoxvirus having increased immunogenicity8 Feb 2024US 2024/0043870 A1Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Modified parapoxvirus having increased immunogenicity25 Jan 2024US 2024/0024464 A1Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
- Recombinant poxviridae vector expressing co-stimulatory molecules26 Oct 2023US 2023/0338516 A1Prime Vector Technologies GmbH
Most cited
By later US patents